What happened?
WHO reports that, as of 6 October 2026, the Bundibugyo virus disease outbreak in the Democratic Republic of the Congo has reached 8 728 laboratory‑confirmed cases and 4 205 confirmed deaths (crude CFR 48.2%). Transmission remains concentrated in eastern provinces but has expanded geographically. Kenya reported one laboratory‑confirmed imported case who died; a healthcare worker was medically evacuated to the Netherlands.
Why does it matter?
The outbreak is large, geographically expanding and associated with high mortality and many community deaths, indicating delays in care. Gaps in contact follow‑up and continued health‑care transmission increase the risk of further spread and international importations.
How to interpret the evidence
People living in or moving through affected health zones in eastern DRC face the highest exposure risk. WHO rates national risk very high and risk to border countries high, while global risk is low. There is material uncertainty about local resources and EU/Malta applicability; do not assume local access to specific vaccines or treatments.
What remains uncertain?
This report does not indicate the existence of approved specific treatments or widely available vaccines for Bundibugyo virus. It does not, by itself, justify travel or trade restrictions — WHO advises against such general measures and assessments are ongoing.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.
This summary was prepared with AI assistance and checked automatically against the linked primary source. It has not been individually reviewed by a clinician.